UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc P(1)
    Brian Link
  2. GOG 3001/ Amgen TRINOVA-3 - A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III…
    David Bender
  3. Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab...
    Ayman El-Sheikh
  4. A Phase III Randomized Trial of Gemcitabine (NSC# 613327) plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) vs. Observation for Uterus-limited, High Grade Uterine Leiomyosarcoma
    David Bender
  5. A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Lenalidomide...
    Brian Link
  6. A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton
    Brian Link
  7. A Phase 1b/2, Multicenter, Open-label Trial to Evaluate the Safety and Efficacy of Talimogene Laherparepvec and Ipilimumab Compared to Ipilimumab...
    Mohammed Milhem
  8. Randomized, double-blind phase III study of Pazopanib vs Placebo in subjects with metastatic renal cell carcinoma who have no evidence of disease...
    Daniel Vaena
  9. A Phase 2 Study of MLN8237 in Advanced / Metastatic Sarcoma(1)
    Mohammed Milhem
  10. Biobehavioral-Cytokine Interactions in Ovarian Cancer
    Susan Lutgendorf
  11. Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc Positive Diffuse Large B-Cell Lymphoma and Plasmablastic...
    Brian Link
  12. A Phase III Randomized Trial of Adding Vincristine-topotecan-cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma
    Ayman El-Sheikh
  13. A randomized phase II study of Azacitidine in combination with Lenalidomide (NSC-703812) vs Azacitid(1)
    Thomas Carter
  14. Phase 2 study of the mTOR inhibitor everolimus in combination with bevacizumab in patients with sporadic and neurofibromatosis type 1 (NF1) related...
    Mohammed Milhem
  15. Evaluation of Genes and Proteins in Pediatric Nervous System Tumors
    M. Sue O
  16. A Group-Wide Protocol for Collecting and Banking Research Specimens
    Ayman El-Sheikh
  17. Molecular Genetic Features of Acute Leukemia (CALGB 9862)
    Daniel Vaena
  18. Neuroblastoma Biology Studies
    Ayman El-Sheikh
  19. A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris suis Ova Treatment in Left-sided Ulcerative Colitis and its Effects on Mucosal Immune State and Microbi…
    Steven Polyak
  20. Vocal Cord Injury in Preterms: the VIP Study
    Edward F. Bell

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.